Zhaoke Ophthalmology's Half-Year Results: Net Loss Widens to RMB 123 Million Amid Rising Costs
Stock News
Aug 28
Zhaoke Ophthalmology-B (06622) has released its interim results for the 2026 fiscal year, showing total revenue of RMB 18.828 million, a year-on-year increase of 19.14%. However, the company recorded a net loss of approximately RMB 123 million, which represents a 5.12% rise compared to the prior corresponding period, translating to a loss per share of RMB 0.22.
The uptick in losses was primarily attributed to a decline in interest income from bank deposits, reflecting the downward trend in global interest rates since mid-2025. Additionally, the company recognized higher share-based payment expenses within its general and administrative costs during the period, further impacting the bottom line.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.